These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 2884526)

  • 21. Immunoglobulin by infusion.
    van der Meer JW; Dooren LJ
    Lancet; 1980 Feb; 1(8163):318. PubMed ID: 6101776
    [No Abstract]   [Full Text] [Related]  

  • 22. [Use of immunoglobulins in pediatrics].
    Fischer A
    Arch Fr Pediatr; 1988 Dec; 45(10):779-81. PubMed ID: 3071284
    [No Abstract]   [Full Text] [Related]  

  • 23. Long-term parenteral exposure to mercury in patients with hypogammaglobulinaemia.
    Haeney MR; Carter GF; Yeoman WB; Thompson RA
    Br Med J; 1979 Jul; 2(6181):12-4. PubMed ID: 466248
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The use of intravenous immunoglobulins: recommendations of a consensus conference of the working group of immunology of the Italian Society of Pediatrics.
    Ann Allergy; 1989 Apr; 62(4):362-7. PubMed ID: 2495747
    [No Abstract]   [Full Text] [Related]  

  • 25. Solid organ transplantation: hypogammaglobulinaemia and infectious complications after solid organ transplantation.
    Florescu DF
    Clin Exp Immunol; 2014 Dec; 178 Suppl 1(Suppl 1):54-6. PubMed ID: 25546761
    [No Abstract]   [Full Text] [Related]  

  • 26. [Variable immune deficiency syndrome with antibody deficiency--long-term substitution with immunoglobulins].
    Vaith P; Maas D
    Immun Infekt; 1984 Apr; 12(2):123-8. PubMed ID: 6442916
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sarcoidosis and primary hypogammaglobulinaemia: a report of two cases and a review of the literature.
    Leen CL; Bath JC; Brettle RP; Yap PL
    Sarcoidosis; 1985 Sep; 2(2):91-5. PubMed ID: 3939612
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intravenous immunoglobulin in antibody deficiency syndromes.
    Hanson LA; Björkander J; Wadsworth C; Bake B
    Lancet; 1982 Feb; 1(8268):396. PubMed ID: 6120372
    [No Abstract]   [Full Text] [Related]  

  • 29. Survival of antigen-specific antibody following administration of intravenous immunoglobulin in patients with primary immunodeficiency diseases.
    Fischer SH; Ochs HD; Wedgwood RJ; Skvaril F; Morell A; Hill HR; Schiffmann G; Corey L
    Monogr Allergy; 1988; 23():225-35. PubMed ID: 3386642
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Simultaneous Streptococcus pneumoniae, Giardia lamblia and Campylobacter pylori infection: an adult presentation of X-linked hypogammaglobulinaemia.
    Nathwani D; Morris AJ; Smith CC
    Scott Med J; 1989 Aug; 34(4):502. PubMed ID: 2638574
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hypogammaglobulinaemia in the United Kingdom. VI. The metabolism of IgG in hypogammaglobulinaemia.
    Freeman T
    Spec Rep Ser Med Res Counc (G B); 1971; 310():67-71. PubMed ID: 5573488
    [No Abstract]   [Full Text] [Related]  

  • 32. [Substitution with immunoglobulins in primary antibody deficiency syndrome].
    Morell A; Barandun S
    Beitr Infusionther Klin Ernahr; 1982; 9():16-24. PubMed ID: 6756383
    [No Abstract]   [Full Text] [Related]  

  • 33. Prospective open-label study of pharmacokinetics, efficacy and safety of a new 10% liquid intravenous immunoglobulin in patients with hypo- or agammaglobulinemia.
    Björkander J; Nikoskelainen J; Leibl H; Lanbeck P; Wallvik J; Lumio JT; Braconier JH; Pavlova BG; Birthistle K; Engl W; Walter S; Ehrlich HJ
    Vox Sang; 2006 May; 90(4):286-93. PubMed ID: 16635071
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy and safety of Hizentra(®) in patients with primary immunodeficiency after a dose-equivalent switch from intravenous or subcutaneous replacement therapy.
    Jolles S; Bernatowska E; de Gracia J; Borte M; Cristea V; Peter HH; Belohradsky BH; Wahn V; Neufang-Hüber J; Zenker O; Grimbacher B
    Clin Immunol; 2011 Oct; 141(1):90-102. PubMed ID: 21705277
    [TBL] [Abstract][Full Text] [Related]  

  • 35. IgE content of commercial intravenous IgG preparations.
    Tovo PA; Gabiano C; Grazia Roncarolo M; Altare F
    Lancet; 1984 Feb; 1(8374):458. PubMed ID: 6142191
    [No Abstract]   [Full Text] [Related]  

  • 36. Comparison of the clinical efficacy and safety of an intramuscular and an intravenous immunoglobulin preparation for replacement therapy in idiopathic adult onset panhypogammaglobulinaemia.
    Garbett ND; Currie DC; Cole PJ
    Clin Exp Immunol; 1989 Apr; 76(1):1-7. PubMed ID: 2500273
    [TBL] [Abstract][Full Text] [Related]  

  • 37. X-linked hypogammaglobulinaemia with a late secretion defect. A family study.
    Schütt C; Eggers G; Wegener S; Seyfarth M; Peters E; Mach M; Erdmann D
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1987; 114(3):382-9. PubMed ID: 2444512
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Repeated courses of rituximab for autoimmune cytopenias may precipitate profound hypogammaglobulinaemia requiring replacement intravenous immunoglobulin.
    Cooper N; Davies EG; Thrasher AJ
    Br J Haematol; 2009 Jun; 146(1):120-2. PubMed ID: 19438506
    [No Abstract]   [Full Text] [Related]  

  • 39. Intravenous administration of plasmin treated immunoglobulins in 10 patients with agammaglobulinemia.
    Luzi G; Bonomo R; Frielingsdorf A; Palmisano L; Zolla S; Seminara R; Fiorilli M; Barbato M; Aiuti F
    Ann Sclavo; 1981; 23(4):413-20. PubMed ID: 6179481
    [No Abstract]   [Full Text] [Related]  

  • 40. Subcutaneous immunoglobulin home treatment in hypogammaglobulinaemia.
    Leahy MF
    Lancet; 1986 Jul; 2(8497):48. PubMed ID: 2873349
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.